News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mahadevia Ankit
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Mahadevia Ankit (See Remarks) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 179,319 options to buy
@ $19.18, valued at
$3.4M
|
|
| 11/05/2020 |
4
| Mahadevia Ankit (CEO and President) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Sold 2,137 shares
@ $14.2675, valued at
$30.5k
Sold 7,370 shares
@ $14.4281, valued at
$106.3k
Exercised 2,137 options to buy
@ $5.9, valued at
$12.6k
Exercised 7,370 options to buy
@ $5.9, valued at
$43.5k
|
|
| 10/27/2020 |
4
| Mahadevia Ankit (CEO and President) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Sold 20 shares
@ $14.25, valued at
$285
Exercised 20 options to buy
@ $5.9, valued at
$118 |
|
| 10/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2020 |
4
| Mahadevia Ankit (CEO and President) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Sold 774 shares
@ $14.2503, valued at
$11k
Exercised 774 options to buy
@ $5.9, valued at
$4.6k
|
|
| 07/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2020 |
4
| Mahadevia Ankit (CEO and President) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 180,000 options to buy
@ $9.34, valued at
$1.7M
|
|
| 01/02/2019 |
4
| Mahadevia Ankit (CEO and President) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 180,000 options to buy
@ $6.26, valued at
$1.1M
|
|
| 07/06/2018 |
4
| Mahadevia Ankit (See Remarks) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Sold 3,076 shares
@ $17.6215, valued at
$54.2k
Sold 500 shares
@ $17.5, valued at
$8.8k
Sold 100 shares
@ $17.545, valued at
$1.8k
Sold 400 shares
@ $17.58, valued at
$7k
Sold 100 shares
@ $17.62, valued at
$1.8k
Sold 100 shares
@ $17.705, valued at
$1.8k
Sold 200 shares
@ $17.9, valued at
$3.6k
Sold 200 shares
@ $17.92, valued at
$3.6k
Exercised 3,076 options to buy
@ $5.9, valued at
$18.1k
Exercised 1,600 options to buy
@ $5.9, valued at
$9.4k
|
|
| 12/15/2017 |
4
| Mahadevia Ankit (See Remarks) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 125,079 options to buy
@ $11.63, valued at
$1.5M
|
|
| 11/01/2017 |
3
| Mahadevia Ankit (See Remarks) has filed a Form 3 on Spero Therapeutics, Inc. |
|
|